- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
research use only
Cat.No.S7400
| Related Targets | Bcl-2 Caspase K-Ras PD-1/PD-L1 Ferroptosis p53 Apoptosis related Synthetic Lethality STAT TNF-alpha |
|---|---|
| Other PERK Inhibitors | GSK2606414 GSK2656157 Salubrinal Sal003 Azoramide BTdCPU CCT020312 AMG PERK 44 MK-28 |
|
In vitro |
DMSO
: 5 mg/mL
(11.07 mM)
Water : Insoluble Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 451.34 | Formula | C22H24Cl2N2O4
|
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1597403-47-8 | -- | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C1CC(CCC1NC(=O)COC2=CC=C(C=C2)Cl)NC(=O)COC3=CC=C(C=C3)Cl | ||
| Targets/IC50/Ki |
PERK
(Cell-free assay) 5 nM
|
|---|---|
| In vitro |
ISRIB (trans-isomer) blocks production of endogenous ATF4, whereas XBP1 mRNA splicing and XBP1s production persisted. It prevents cells from re-establishing ER homeostasis by blocking signaling through the PERK branch of the UPR, and decreases the viability of cells that are subjected to ER-stress. |
| Kinase Assay |
High-content microscopy-based secondary screen
|
|
U2OS cells carrying the ATF4-dGFP-IRES-Cherry reporter are plated in 96 well plates and treated with 100 nM Thapsigargin and 10μM of the cherry-picked compounds for 8 hr, including ISRIB (trans-isomer). Cells are stained with Hoechst 33,258 and are visualized using an automated microscope. Data acquisition and image analyses are performed with the INCell Developer Toolbox Software, version 1.9. Compounds that block induction of the ATF4-dGFP reporter, do not block the accumulation of mCherry downstream of the IRES, and are deemed non-toxic as determined by cell number measured by counting nuclei, are repurchased for further analyses.
|
|
| In vivo |
ISRIB (trans-isomer) shows favorable properties in pharmacokinetic profiling experiments and good bioavailability in vivo. This compound (0.25 mg/kg i.p.) increases long-term memory in mice by enhancing spatial and fear-associated learning. |
References |
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Western blot | PERK / XBP1s / ATF4 |
|
23741617 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.